Progressive Care Expands COVID-19 Testing Capabilities to Meet Increased Demand

July 13, 2020

MIAMI, FL – July 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that it has sold through over 90% of its COVID-19 Antibody testing kits. The Company has ordered additional kits and will be expanding testing to meet increasing needs.

The Company, as of July 13, 2020, has sold through over 90% of its COVID-19 Antibody test kits and has processed a re-order to meet increasing demand. Appointments at the Company’s Miami location have been fully booked as Florida marks record breaking testing and positivity rates. The Company is expanding antibody testing to offer services to Palm Beach County, Florida and launching on-site services to enable antibody testing services for employees at their employment sites. The Company has been working with several referral sources including local labs, healthcare professionals, employers/business owners, and local airline affiliates who see the need and benefit of rapid antibody testing to enhance health safety initiatives.

New testing requirements by employers and travel-related businesses are placing a heavier burden on communities to get tested and be tested more frequently. With high demand, patients are waiting in long lines and up to 10 days to get results for COVID-19 antigen tests. Antibody tests can help employers and health care professionals assess the incidence of exposure among their group. In addition, the Company is working to secure COVID-19 antigen test kits to enable diagnostic testing at its facilities.

“Progressive Care has always been at the forefront of closing gaps in healthcare,” said S. Mars, CEO. “Our testing capabilities are steadily increasing to meet the high and urgent needs of our communities and we will continue to seek out every available avenue to provide support during this pandemic and beyond.”

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

PharmCo, LLC

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

ClearMetrX

https://www.clearmetrx.com/

https://www.facebook.com/clearmetrx/

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries a personalized healthcare services and

technology company which provides prescription pharmaceutical services, risk management and data

analytics to healthcare organizations and providers.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in

nature and constitute forward-looking statements within the meaning of Section 27A of the Securities

Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements

reflect the Company’s expectations about its future operating results, performance, and opportunities

that involve substantial risks and uncertainties. These statements include but are not limited to

statements regarding the intended terms of the offering, closing of the offering and use of any proceeds

from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,”

“target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its

subsidiaries, or its management, are intended to identify such forward-looking statements. These

forward-looking statements are based on information currently available to the Company and are

subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual

results, performance, prospects, and opportunities to differ materially from those expressed in, or

implied by, these forward-looking statements.

Investor Relations Contact:

Armen Karapetyan, Progressive Care

Senior Advisor Business Development

Armen@progressivecareus.com

www.progressivecareus.com

www.pharmcopharmacy.com

Public Relations Contact:

Carlos Rangel

carlosr@pharmcorx.com

Investors' Presentation